Cover Image
Market Research Report

Latin America, Middle East & Africa Stroke Management Market (2018 - 2024)

Published by KBV Research Product code 763783
Published Content info 98 Pages
Delivery time: 1-2 business days
Price
Back to Top
Latin America, Middle East & Africa Stroke Management Market (2018 - 2024)
Published: December 20, 2018 Content info: 98 Pages
Description

The Latin America, Middle East and Africa Stroke Management Market would witness market growth of 8.0% CAGR during the forecast period (2018 - 2024). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advances devices and drugs would limit the market growth. Rising investments to upgrade healthcare systems and demand for technologically advanced devices for rapid & accurate distribution of medicines are the factors that are driving the market in the region. Research and development activities in the region would further add to the market attractiveness in the region.

Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.

Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Stroke Management Market, by Type
    • 1.4.2 LAMEA Stroke Management Market, by Application
    • 1.4.3 LAMEA Stroke Management Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Players Outlook for the Market
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. LAMEA Stroke Management Market by Type

    • 3.1.1 LAMEA Diagnostics Stroke Management Market by Country
      • 3.1.1.1 LAMEA Stroke Management Market by Diagnostics Type
        • 3.1.1.1.1 LAMEA Stroke Management Computed Tomography Scan (CT Scan) Market by Country
        • 3.1.1.1.2 LAMEA Stroke Management Magnetic Resonance Imaging (MRI) Market by Country
        • 3.1.1.1.3 LAMEA Stroke Management Echocardiography Market by Country
        • 3.1.1.1.4 LAMEA Stroke Management Carotid Ultrasound Market by Country
        • 3.1.1.1.5 LAMEA Stroke Management Cerebral Angiography Market by Country
        • 3.1.1.1.6 LAMEA Stroke Management Electrocardiography Market by Country
        • 3.1.1.1.7 LAMEA Other Diagnostics Type Stroke Management Market by Country
    • 3.1.2 LAMEA Therapeutics Stroke Management Market by Country
      • 3.1.2.1 LAMEA Stroke Management Market by Therapeutics Type
        • 3.1.2.1.1 LAMEA Tissue Plasminogen Activator Stroke Management Market by Country
        • 3.1.2.1.2 LAMEA Anticoagulant Stroke Management Market by Country
        • 3.1.2.1.3 LAMEA Antiplatelet Stroke Management Market by Country
        • 3.1.2.1.4 LAMEA Other Therapeutics Type Stroke Management Market by Country

Chapter 4. LAMEA Stroke Management Market by Application

    • 4.1.1 LAMEA Ischemic Stroke Management Market by Country
    • 4.1.2 LAMEA Hemorrhagic Stroke Management Market by Country

Chapter 5. LAMEA Stroke Management Market by Country

  • 5.1 Brazil Stroke Management Market
    • 5.1.1 Brazil Stroke Management Market by Type
      • 5.1.1.1 Brazil Stroke Management Market by Diagnostics Type
      • 5.1.1.2 Brazil Stroke Management Market by Therapeutics Type
    • 5.1.2 Brazil Stroke Management Market by Application
  • 5.2 Argentina Stroke Management Market
    • 5.2.1 Argentina Stroke Management Market by Type
      • 5.2.1.1 Argentina Stroke Management Market by Diagnostics Type
      • 5.2.1.2 Argentina Stroke Management Market by Therapeutics Type
    • 5.2.2 Argentina Stroke Management Market by Application
  • 5.3 UAE Stroke Management Market
    • 5.3.1 UAE Stroke Management Market by Type
      • 5.3.1.1 UAE Stroke Management Market by Diagnostics Type
      • 5.3.1.2 UAE Stroke Management Market by Therapeutics Type
    • 5.3.2 UAE Stroke Management Market by Application
  • 5.4 Saudi Arabia Stroke Management Market
    • 5.4.1 Saudi Arabia Stroke Management Market by Type
      • 5.4.1.1 Saudi Arabia Stroke Management Market by Diagnostics Type
      • 5.4.1.2 Saudi Arabia Stroke Management Market by Therapeutics Type
    • 5.4.2 Saudi Arabia Stroke Management Market by Application
  • 5.5 South Africa Stroke Management Market
    • 5.5.1 South Africa Stroke Management Market by Type
      • 5.5.1.1 South Africa Stroke Management Market by Diagnostics Type
      • 5.5.1.2 South Africa Stroke Management Market by Therapeutics Type
    • 5.5.2 South Africa Stroke Management Market by Application
  • 5.6 Nigeria Stroke Management Market
    • 5.6.1 Nigeria Stroke Management Market by Type
      • 5.6.1.1 Nigeria Stroke Management Market by Diagnostics Type
      • 5.6.1.2 Nigeria Stroke Management Market by Therapeutics Type
    • 5.6.2 Nigeria Stroke Management Market by Application
  • 5.7 Rest of LAMEA Stroke Management Market
    • 5.7.1 Rest of LAMEA Stroke Management Market by Type
      • 5.7.1.1 Rest of LAMEA Stroke Management Market by Diagnostics Type
      • 5.7.1.2 Rest of LAMEA Stroke Management Market by Therapeutics Type
    • 5.7.2 Rest of LAMEA Stroke Management Market by Application

Chapter 6. Company Profiles

  • 6.1 B. Braun Melsungen AG.
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental Analysis
    • 6.1.4 Research & Development Expense
  • 6.2 ABBOTT
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Regional & Segmental Analysis
    • 6.2.4 Research & Development Expense
  • 6.3 Cardinal Health
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Segmental Analysis
  • 6.4 Medtronic Plc.
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Segmental and Regional Analysis
    • 6.4.4 Research & Development Expense
  • 6.5 General Electric (GE) (GE Healthcare)
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Segmental and Regional Analysis
    • 6.5.4 Research & Development Expense
  • 6.6 Siemens Healthineers
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Segmental Analysis
    • 6.6.4 Research & Development Expense
  • 6.7 Bristol-Myers Squibb
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Regional Analysis
    • 6.7.4 Research & Development Expense
  • 6.8 Merck & Company Inc.
    • 6.8.1 Company Overview
    • 6.8.2 Financial Analysis
    • 6.8.3 Segmental Analysis
    • 6.8.4 Research & Development Expense
  • 6.9 Glaxosmithkline Plc.
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Segmental Analysis
    • 6.9.4 Research & Development Expense

LIST OF TABLES

  • TABLE 1 LAMEA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 2 LAMEA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 3 LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 4 LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 5 LAMEA DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 6 LAMEA DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 7 LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 8 LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 9 LAMEA STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 10 LAMEA STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 11 LAMEA STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 12 LAMEA STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 13 LAMEA STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 14 LAMEA STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 15 LAMEA STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 16 LAMEA STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 17 LAMEA STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 18 LAMEA STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 19 LAMEA STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 20 LAMEA STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 21 LAMEA OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 22 LAMEA OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 23 LAMEA THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 24 LAMEA THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 25 LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 26 LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 27 LAMEA TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 28 LAMEA TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 29 LAMEA ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 30 LAMEA ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 31 LAMEA ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 32 LAMEA ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 33 LAMEA OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 34 LAMEA OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 35 LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 36 LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 37 LAMEA ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 38 LAMEA ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 39 LAMEA HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 40 LAMEA HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 41 LAMEA STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 42 LAMEA STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 43 BRAZIL STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 44 BRAZIL STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 45 BRAZIL STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 46 BRAZIL STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 47 BRAZIL STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 48 BRAZIL STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 49 BRAZIL STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 50 BRAZIL STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 51 BRAZIL STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 52 BRAZIL STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 53 ARGENTINA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 54 ARGENTINA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 55 ARGENTINA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 56 ARGENTINA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 57 ARGENTINA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 58 ARGENTINA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 59 ARGENTINA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 60 ARGENTINA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 61 ARGENTINA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 62 ARGENTINA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 63 UAE STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 64 UAE STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 65 UAE STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 66 UAE STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 67 UAE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 68 UAE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 69 UAE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 70 UAE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 71 UAE STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 72 UAE STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 73 SAUDI ARABIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 74 SAUDI ARABIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 75 SAUDI ARABIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 76 SAUDI ARABIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 77 SAUDI ARABIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 78 SAUDI ARABIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 79 SAUDI ARABIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 80 SAUDI ARABIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 81 SAUDI ARABIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 82 SAUDI ARABIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 83 SOUTH AFRICA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 84 SOUTH AFRICA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 85 SOUTH AFRICA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 86 SOUTH AFRICA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 87 SOUTH AFRICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 88 SOUTH AFRICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 89 SOUTH AFRICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 90 SOUTH AFRICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 91 SOUTH AFRICA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 92 SOUTH AFRICA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 93 NIGERIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 94 NIGERIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 95 NIGERIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 96 NIGERIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 97 NIGERIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 98 NIGERIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 99 NIGERIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 100 NIGERIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 101 NIGERIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 102 NIGERIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 103 REST OF LAMEA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 104 REST OF LAMEA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 105 REST OF LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 106 REST OF LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 107 REST OF LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 108 REST OF LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 109 REST OF LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 110 REST OF LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 111 REST OF LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 112 REST OF LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 113 KEY INFORMATION - B. BRAUN MELSUNGEN AG
  • TABLE 114 KEY INFORMATION - ABBOTT
  • TABLE 115 KEY INFORMATION - CARDINAL HEALTH
  • TABLE 116 BUSINESS SEGMENT - CARDINAL HEALTH
  • TABLE 117 KEY INFORMATION - MEDTRONIC PLC
  • TABLE 118 KEY INFORMATION - MEDTRONIC
  • TABLE 119 KEY INFORMATION - GENERAL ELECTRIC (GE)
  • TABLE 120 KEY INFORMATION - SIEMENS HEALTHINEERS
  • TABLE 121 KEY INFORMATION - BRISTOL-MYERS SQUIBB
  • TABLE 122 KEY INFORMATION - MERCK & COMPANY INC.
  • TABLE 123 KEY INFORMATION - GLAXOSMITHKLINE PLC.
Back to Top